{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:04:11Z","timestamp":1793397851738,"version":"4.5.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T00:00:00Z","timestamp":1675036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T00:00:00Z","timestamp":1675036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003500","name":"Universit\u00e0 degli Studi di Padova","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003500","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Aims<\/jats:title>\n                <jats:p>The aim of the present study was to evaluate, by means of a meta-analysis approach, whether new available data, appeared on qualified literature, can support the effectiveness of an association of HbA1c variability with the risk of macro- and\/or micro-vascular complications in type 2 diabetes mellitus (T2DM).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The meta-analysis was conducted according to PRISMA Statement guidelines and considered published studies on T2DM, presenting HbA1c variability as standard deviation (SD) or its derived coefficient of variation (CV). Literature search was performed on PubMed in the time range 2015\u2013July 2022, with no restrictions of language.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Twenty-three selected studies fulfilled the aims of the present investigation. Overall, the analysis of the risk as hazard ratios (HR) indicated a significant association between the HbA1c variability, expressed either as SD or CV, and the complications, except for neuropathy. Macro-vascular complications were all significantly associated with HbA1c variability, with HR 1.40 (95%CI 1.31\u20131.50, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001) for stroke, 1.30 (95%CI 1.25\u20131.36, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001) for transient ischaemic attack\/coronary heart disease\/myocardial infarction, and 1.32 (95%CI 1.13\u20131.56, <jats:italic>p<\/jats:italic>\u2009=\u20090.0007) for peripheral arterial disease. Micro-vascular complications yielded HR 1.29 (95%CI 1.22\u20131.36, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001) for nephropathy, 1.03 (95%CI 0.99\u20131.08, <jats:italic>p<\/jats:italic>\u2009=\u20090.14) for neuropathy, and 1.15 (95%CI 1.08\u20131.24, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001) for retinopathy. For all-cause mortality, HR was 1.33 (95%CI 1.27\u20131.39, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001), and for cardiovascular mortality 1.25 (95%CI 1.17\u20131.34, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our meta-analysis on HbA1c variability performed on the most recent published data since 2015 indicates positive association between HbA1c variability and macro-\/micro-vascular complications, as well as mortality events, in T2DM, suggesting that this long-term glycaemic parameter merits further attention as a predictive, independent risk factor for T2DM population.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00592-023-02037-8","type":"journal-article","created":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T11:02:57Z","timestamp":1675076577000},"page":"721-738","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":89,"title":["Long-term HbA1c variability and macro-\/micro-vascular complications in type 2 diabetes mellitus: a meta-analysis update"],"prefix":"10.1007","volume":"60","author":[{"given":"Giovanni","family":"Sartore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0390-6823","authenticated-orcid":false,"given":"Eugenio","family":"Ragazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosaria","family":"Caprino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annunziata","family":"Lapolla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,30]]},"reference":[{"issue":"7","key":"2037_CR1","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.2337\/dc09-9033","volume":"32","author":"International Expert Committee","year":"2009","unstructured":"International Expert Committee (2009) International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 32(7):1327\u20131334. https:\/\/doi.org\/10.2337\/dc09-9033","journal-title":"Diabetes Care"},{"issue":"1","key":"2037_CR2","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1515\/cclm-2012-0548","volume":"51","author":"P Gillery","year":"2013","unstructured":"Gillery P (2013) A history of HbA1c through clinical chemistry and laboratory medicine. Clin Chem Lab Med 51(1):65\u201374. https:\/\/doi.org\/10.1515\/cclm-2012-0548","journal-title":"Clin Chem Lab Med"},{"issue":"Suppl 1","key":"2037_CR3","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.2337\/dc10-S062.Erratum.In:DiabetesCare.2010Apr;33(4):e57","volume":"33","author":"American Diabetes Association","year":"2010","unstructured":"American Diabetes Association (2010) Diagnosis and classification of diabetes mellitus. Diabetes Care 33(Suppl 1):S62\u2013S69. https:\/\/doi.org\/10.2337\/dc10-S062.Erratum.In:DiabetesCare.2010Apr;33(4):e57","journal-title":"Diabetes Care"},{"issue":"5","key":"2037_CR4","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1046\/j.1365-2125.1999.00092.x","volume":"48","author":"P King","year":"1999","unstructured":"King P, Peacock I, Donnelly R (1999) The UK prospective diabetes study (UKPDS): clinical and therapeutic implications for type 2 diabetes. Br J Clin Pharmacol 48(5):643\u2013648. https:\/\/doi.org\/10.1046\/j.1365-2125.1999.00092.x","journal-title":"Br J Clin Pharmacol"},{"issue":"Suppl 2","key":"2037_CR5","doi-asserted-by":"publisher","first-page":"S357","DOI":"10.2337\/dc09-S339","volume":"32","author":"SR Heller","year":"2009","unstructured":"Heller SR, ADVANCE Collaborative Group (2009) A summary of the ADVANCE Trial. Diabetes Care 32(Suppl 2):S357\u2013S361. https:\/\/doi.org\/10.2337\/dc09-S339","journal-title":"Diabetes Care"},{"issue":"14","key":"2037_CR6","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1001\/jama.2015.8345","volume":"314","author":"ES Huang","year":"2015","unstructured":"Huang ES, Davis AM (2015) Glycemic control in older adults with diabetes mellitus. JAMA 314(14):1509\u20131510. https:\/\/doi.org\/10.1001\/jama.2015.8345","journal-title":"JAMA"},{"issue":"6","key":"2037_CR7","doi-asserted-by":"publisher","first-page":"413","DOI":"10.7326\/0003-4819-141-6-200409210-00006","volume":"141","author":"KT Khaw","year":"2004","unstructured":"Khaw KT, Wareham N, Bingham S, Luben R, Welch A, Day N (2004) Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann Intern Med 141(6):413\u2013420. https:\/\/doi.org\/10.7326\/0003-4819-141-6-200409210-00006","journal-title":"Ann Intern Med"},{"issue":"9","key":"2037_CR8","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1056\/NEJMoa0908359","volume":"362","author":"E Selvin","year":"2010","unstructured":"Selvin E, Steffes MW, Zhu H et al (2010) Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med 362(9):800\u2013811. https:\/\/doi.org\/10.1056\/NEJMoa0908359","journal-title":"N Engl J Med"},{"issue":"12A","key":"2037_CR9","doi-asserted-by":"publisher","first-page":"21i","DOI":"10.1016\/j.amjcard.2007.03.003","volume":"99","author":"JB Buse","year":"2007","unstructured":"Buse JB, Bigger JT, Byington RP et al (2007) Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods. Am J Cardiol 99(12A):21i\u201333i. https:\/\/doi.org\/10.1016\/j.amjcard.2007.03.003","journal-title":"Am J Cardiol"},{"issue":"2","key":"2037_CR10","doi-asserted-by":"publisher","first-page":"426","DOI":"10.2337\/dc19-0823","volume":"43","author":"S Li","year":"2020","unstructured":"Li S, Nemeth I, Donnelly L, Hapca S, Zhou K, Pearson ER (2020) Visit-to-visit HbA1c variability is associated with cardiovascular disease and microvascular complications in patients with newly diagnosed type 2 diabetes. Diabetes Care 43(2):426\u2013432. https:\/\/doi.org\/10.2337\/dc19-0823","journal-title":"Diabetes Care"},{"issue":"6","key":"2037_CR11","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/S2213-8587(18)30048-2","volume":"6","author":"A Forbes","year":"2018","unstructured":"Forbes A, Murrells T, Mulnier H, Sinclair AJ (2018) Mean HbA1c, HbA1c variability, and mortality in people with diabetes aged 70 years and older: a retrospective cohort study. Lancet Diabetes Endocrinol 6(6):476\u2013486. https:\/\/doi.org\/10.1016\/S2213-8587(18)30048-2","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"2037_CR12","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12933-018-0693-0","volume":"17","author":"JB Su","year":"2018","unstructured":"Su JB, Zhao LH, Zhang XL et al (2018) HbA1c variability and diabetic peripheral neuropathy in type 2 diabetic patients. Cardiovasc Diabetol 17(1):47. https:\/\/doi.org\/10.1186\/s12933-018-0693-0","journal-title":"Cardiovasc Diabetol"},{"issue":"9718","key":"2037_CR13","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/S0140-6736(10)60308-X","volume":"375","author":"PM Rothwell","year":"2010","unstructured":"Rothwell PM, Howard SC, Dolan E et al (2010) Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 375(9718):895\u2013905. https:\/\/doi.org\/10.1016\/S0140-6736(10)60308-X","journal-title":"Lancet"},{"issue":"2","key":"2037_CR14","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/s00125-015-3797-z","volume":"59","author":"FC Bonke","year":"2016","unstructured":"Bonke FC, Donnachie E, Schneider A, Mehring M (2016) Association of the average rate of change in HbA1c with severe adverse events: a longitudinal evaluation of audit data from the Bavarian disease management program for patients with type 2 diabetes mellitus. Diabetologia 59(2):286\u2013293. https:\/\/doi.org\/10.1007\/s00125-015-3797-z","journal-title":"Diabetologia"},{"issue":"12","key":"2037_CR15","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.2337\/dc15-1188","volume":"38","author":"C Gorst","year":"2015","unstructured":"Gorst C, Kwok CS, Aslam S et al (2015) Long-term glycemic variability and risk of adverse outcomes: a systematic review and meta-analysis. Diabetes Care 38(12):2354\u20132369. https:\/\/doi.org\/10.2337\/dc15-1188","journal-title":"Diabetes Care"},{"issue":"7","key":"2037_CR16","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7):e1000097. https:\/\/doi.org\/10.1371\/journal.pmed.1000097","journal-title":"PLoS Med"},{"issue":"11","key":"2037_CR17","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.2337\/dc08-0864","volume":"31","author":"ES Kilpatrick","year":"2008","unstructured":"Kilpatrick ES, Rigby AS, Atkin SL (2008) A1C variability and the risk of microvascular complications in type 1 diabetes: data from the diabetes control and complications trial. Diabetes Care 31(11):2198\u20132202. https:\/\/doi.org\/10.2337\/dc08-0864","journal-title":"Diabetes Care"},{"issue":"6","key":"2037_CR18","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.2337\/dc19-2589","volume":"43","author":"CS Sheng","year":"2020","unstructured":"Sheng CS, Tian J, Miao Y et al (2020) Prognostic significance of long-term HbA1c variability for all-cause mortality in the ACCORD trial. Diabetes Care 43(6):1185\u20131190. https:\/\/doi.org\/10.2337\/dc19-2589","journal-title":"Diabetes Care"},{"key":"2037_CR19","first-page":"359","volume":"2006","author":"X Huang","year":"2006","unstructured":"Huang X, Lin J, Demner-Fushman D (2006) Evaluation of PICO as a knowledge representation for clinical questions. AMIA Annu Symp Proc 2006:359\u2013363","journal-title":"AMIA Annu Symp Proc"},{"key":"2037_CR20","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1186\/s12913-014-0579-0","volume":"14","author":"AM Methley","year":"2014","unstructured":"Methley AM, Campbell S, Chew-Graham C, McNally R, Cheraghi-Sohi S (2014) PICO, PICOS and SPIDER: a comparison study of specificity and sensitivity in three search tools for qualitative systematic reviews. BMC Health Serv Res 14:579. https:\/\/doi.org\/10.1186\/s12913-014-0579-0","journal-title":"BMC Health Serv Res"},{"issue":"2","key":"2037_CR21","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/jrsm.12","volume":"1","author":"M Borenstein","year":"2010","unstructured":"Borenstein M, Hedges LV, Higgins JP, Rothstein HR (2010) A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods 1(2):97\u2013111. https:\/\/doi.org\/10.1002\/jrsm.12","journal-title":"Res Synth Methods"},{"issue":"4","key":"2037_CR22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.5662\/wjm.v2.i4.27","volume":"2","author":"GA Kelley","year":"2012","unstructured":"Kelley GA, Kelley KS (2012) Statistical models for meta-analysis: a brief tutorial. World J Methodol 2(4):27\u201332. https:\/\/doi.org\/10.5662\/wjm.v2.i4.27","journal-title":"World J Methodol"},{"key":"2037_CR23","unstructured":"Deeks JJ, Higgins JPT, Altman DG (2022) Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (eds) Cochrane handbook for systematic reviews of interventions, version 6.3 (updated February 2022). Cochrane. Available from https:\/\/www.training.cochrane.org\/handbook"},{"issue":"4","key":"2037_CR24","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3121\/cmr.2012.1068","volume":"10","author":"PH Chyou","year":"2012","unstructured":"Chyou PH (2012) A simple and robust way of concluding meta-analysis results using reported P values, standardized effect sizes, or other statistics. Clin Med Res 10(4):219\u2013223. https:\/\/doi.org\/10.3121\/cmr.2012.1068","journal-title":"Clin Med Res"},{"issue":"1","key":"2037_CR25","doi-asserted-by":"publisher","first-page":"e000129","DOI":"10.1136\/bmjdrc-2015-000129","volume":"3","author":"T Takao","year":"2015","unstructured":"Takao T, Matsuyama Y, Suka M, Yanagisawa H, Iwamoto Y (2015) The combined effect of visit-to-visit variability in HbA1c and systolic blood pressure on the incidence of cardiovascular events in patients with type 2 diabetes. BMJ Open Diabetes Res Care 3(1):e000129. https:\/\/doi.org\/10.1136\/bmjdrc-2015-000129","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"12","key":"2037_CR26","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1111\/dme.13166","volume":"33","author":"JC Prentice","year":"2016","unstructured":"Prentice JC, Pizer SD, Conlin PR (2016) Identifying the independent effect of HbA1c variability on adverse health outcomes in patients with type 2 diabetes. Diabet Med 33(12):1640\u20131648. https:\/\/doi.org\/10.1111\/dme.13166","journal-title":"Diabet Med"},{"key":"2037_CR27","doi-asserted-by":"publisher","first-page":"3295747","DOI":"10.1155\/2016\/3295747","volume":"2016","author":"A Takenouchi","year":"2016","unstructured":"Takenouchi A, Tsuboi A, Kurata M, Fukuo K, Kazumi T (2016) Carotid intima-media thickness and visit-to-visit HbA1c variability predict progression of chronic kidney disease in type 2 diabetic patients with preserved kidney function. J Diabetes Res 2016:3295747. https:\/\/doi.org\/10.1155\/2016\/3295747","journal-title":"J Diabetes Res"},{"issue":"7","key":"2037_CR28","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/j.jdiacomp.2016.05.024","volume":"30","author":"EY Wan","year":"2016","unstructured":"Wan EY, Fung CS, Fong DY, Lam CL (2016) Association of variability in hemoglobin A1c with cardiovascular diseases and mortality in Chinese patients with type 2 diabetes mellitus: a retrospective population-based cohort study. J Diabetes Complications 30(7):1240\u20131247. https:\/\/doi.org\/10.1016\/j.jdiacomp.2016.05.024","journal-title":"J Diabetes Complications"},{"key":"2037_CR29","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.diabres.2017.02.007","volume":"128","author":"SR Dorajoo","year":"2017","unstructured":"Dorajoo SR, Ng JSL, Goh JHF et al (2017) HbA1c variability in type 2 diabetes is associated with the occurrence of new-onset albuminuria within three years. Diabetes Res Clin Pract 128:32\u201339. https:\/\/doi.org\/10.1016\/j.diabres.2017.02.007","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"2037_CR30","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/1753-0407.12403","volume":"9","author":"V Foo","year":"2017","unstructured":"Foo V, Quah J, Cheung G et al (2017) HbA1c, systolic blood pressure variability and diabetic retinopathy in Asian type 2 diabetics. J Diabetes 9(2):200\u2013207. https:\/\/doi.org\/10.1111\/1753-0407.12403","journal-title":"J Diabetes"},{"issue":"1","key":"2037_CR31","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s12933-017-0619-2","volume":"16","author":"JE Jun","year":"2017","unstructured":"Jun JE, Lee SE, Lee YB et al (2017) Glycated albumin and its variability as an indicator of cardiovascular autonomic neuropathy development in type 2 diabetic patients. Cardiovasc Diabetol 16(1):127. https:\/\/doi.org\/10.1186\/s12933-017-0619-2","journal-title":"Cardiovasc Diabetol"},{"issue":"6","key":"2037_CR32","doi-asserted-by":"publisher","first-page":"e0178319","DOI":"10.1371\/journal.pone.0178319","volume":"12","author":"MY Lee","year":"2017","unstructured":"Lee MY, Hsiao PJ, Huang YT et al (2017) Greater HbA1c variability is associated with increased cardiovascular events in type 2 diabetes patients with preserved renal function, but not in moderate to advanced chronic kidney disease. PLoS ONE 12(6):e0178319. https:\/\/doi.org\/10.1371\/journal.pone.0178319","journal-title":"PLoS ONE"},{"key":"2037_CR33","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.diabres.2017.03.027","volume":"128","author":"T Takao","year":"2017","unstructured":"Takao T, Suka M, Yanagisawa H, Matsuyama Y, Iwamoto Y (2017) Predictive ability of visit-to-visit variability in HbA1c and systolic blood pressure for the development of microalbuminuria and retinopathy in people with type 2 diabetes. Diabetes Res Clin Pract 128:15\u201323. https:\/\/doi.org\/10.1016\/j.diabres.2017.03.027","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"2037_CR34","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12933-018-0677-0","volume":"17","author":"CRL Cardoso","year":"2018","unstructured":"Cardoso CRL, Leite NC, Moram CBM, Salles GF (2018) Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: the Rio de Janeiro type 2 diabetes cohort study. Cardiovasc Diabetol 17(1):33. https:\/\/doi.org\/10.1186\/s12933-018-0677-0","journal-title":"Cardiovasc Diabetol"},{"issue":"10","key":"2037_CR35","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.2337\/dc18-0548","volume":"41","author":"JJ Zhou","year":"2018","unstructured":"Zhou JJ, Schwenke DC, Bahn G, Reaven P, Investigators VADT (2018) Glycemic variation and cardiovascular risk in the veterans affairs diabetes trial. Diabetes Care 41(10):2187\u20132194. https:\/\/doi.org\/10.2337\/dc18-0548","journal-title":"Diabetes Care"},{"issue":"12","key":"2037_CR36","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.2337\/dc19-0848","volume":"42","author":"JA Critchley","year":"2019","unstructured":"Critchley JA, Carey IM, Harris T, DeWilde S, Cook DG (2019) Variability in glycated hemoglobin and risk of poor outcomes among people with type 2 diabetes in a large primary care cohort study. Diabetes Care 42(12):2237\u20132246. https:\/\/doi.org\/10.2337\/dc19-0848","journal-title":"Diabetes Care"},{"issue":"1","key":"2037_CR37","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12933-020-01147-9","volume":"19","author":"A Ceriello","year":"2020","unstructured":"Ceriello A, Ofstad AP, Zwiener I, Kaspers S, George J, Nicolucci A (2020) Empagliflozin reduced long-term HbA1c variability and cardiovascular death: insights from the EMPA-REG OUTCOME trial. Cardiovasc Diabetol 19(1):176. https:\/\/doi.org\/10.1186\/s12933-020-01147-9","journal-title":"Cardiovasc Diabetol"},{"issue":"10","key":"2037_CR38","doi-asserted-by":"publisher","first-page":"e3638","DOI":"10.1210\/clinem\/dgaa361","volume":"105","author":"ES Scott","year":"2020","unstructured":"Scott ES, Januszewski AS, O\u2019Connell R et al (2020) Long-term glycemic variability and vascular complications in type 2 diabetes: post hoc analysis of the FIELD study. J Clin Endocrinol Metab 105(10):e3638-e3649. https:\/\/doi.org\/10.1210\/clinem\/dgaa361","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2037_CR39","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1111\/dom.14034","volume":"22","author":"EYF Wan","year":"2020","unstructured":"Wan EYF, Yu EYT, Chin WY et al (2020) Age-specific associations of glycated haemoglobin variability with cardiovascular disease and mortality in patients with type 2 diabetes mellitus: a 10- year cohort study. Diabetes Obes Metab 22(8):1316\u20131327. https:\/\/doi.org\/10.1111\/dom.14034","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"2037_CR40","doi-asserted-by":"publisher","first-page":"4731","DOI":"10.1038\/s41598-021-84150-8","volume":"11","author":"HU Kim","year":"2021","unstructured":"Kim HU, Park SP, Kim YK (2021) Long-term HbA1c variability and the development and progression of diabetic retinopathy in subjects with type 2 diabetes. Sci Rep 11(1):4731. https:\/\/doi.org\/10.1038\/s41598-021-84150-8","journal-title":"Sci Rep"},{"issue":"2","key":"2037_CR41","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00592-020-01605-6","volume":"58","author":"S Lee","year":"2021","unstructured":"Lee S, Liu T, Zhou J, Zhang Q, Wong WT, Tse G (2021) Predictions of diabetes complications and mortality using hba1c variability: a 10-year observational cohort study. Acta Diabetol 58(2):171\u2013180. https:\/\/doi.org\/10.1007\/s00592-020-01605-6","journal-title":"Acta Diabetol"},{"issue":"1","key":"2037_CR42","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/dom.14201","volume":"23","author":"Y Shen","year":"2021","unstructured":"Shen Y, Zhou J, Shi L et al (2021) Association between visit-to-visit HbA1c variability and the risk of cardiovascular disease in patients with type 2 diabetes. Diabetes Obes Metab 23(1):125\u2013135. https:\/\/doi.org\/10.1111\/dom.14201","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"2037_CR43","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12933-022-01445-4","volume":"21","author":"A Ceriello","year":"2022","unstructured":"Ceriello A, Lucisano G, Prattichizzo F et al (2022) HbA1c variability predicts cardiovascular complications in type 2 diabetes regardless of being at glycemic target. Cardiovasc Diabetol 21(1):13. https:\/\/doi.org\/10.1186\/s12933-022-01445-4","journal-title":"Cardiovasc Diabetol"},{"key":"2037_CR44","doi-asserted-by":"publisher","first-page":"110069","DOI":"10.1016\/j.diabres.2022.110069","volume":"192","author":"TE Wu","year":"2022","unstructured":"Wu TE, Su YW, Chen HS (2022) Mean HbA1c and HbA1c variability are associated with differing diabetes-related complications in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 192:110069. https:\/\/doi.org\/10.1016\/j.diabres.2022.110069","journal-title":"Diabetes Res Clin Pract"},{"key":"2037_CR45","doi-asserted-by":"publisher","first-page":"6934188","DOI":"10.1155\/2022\/6934188","volume":"2022","author":"Y Yan","year":"2022","unstructured":"Yan Y, Kondo N, Oniki K et al (2022) Predictive Ability of Visit-to-Visit Variability of HbA1c Measurements for the Development of Diabetic Kidney Disease: A Retrospective Longitudinal Observational Study. J Diabetes Res 2022:6934188. https:\/\/doi.org\/10.1155\/2022\/6934188","journal-title":"J Diabetes Res"},{"issue":"10","key":"2037_CR46","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.2337\/dbi20-0002","volume":"69","author":"JM Dennis","year":"2020","unstructured":"Dennis JM (2020) Precision medicine in type 2 diabetes: using individualized prediction models to optimize selection of treatment. Diabetes 69(10):2075\u20132085. https:\/\/doi.org\/10.2337\/dbi20-0002","journal-title":"Diabetes"},{"issue":"3","key":"2037_CR47","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00592-013-0459-9","volume":"50","author":"G Sartore","year":"2013","unstructured":"Sartore G, Chilelli NC, Burlina S, Lapolla A (2013) Association between glucose variability as assessed by continuous glucose monitoring (CGM) and diabetic retinopathy in type 1 and type 2 diabetes. Acta Diabetol 50(3):437\u2013442. https:\/\/doi.org\/10.1007\/s00592-013-0459-9","journal-title":"Acta Diabetol"},{"key":"2037_CR48","doi-asserted-by":"publisher","first-page":"39633","DOI":"10.1038\/srep39633","volume":"6","author":"D Xu","year":"2016","unstructured":"Xu D, Fang H, Xu W, Yan Y, Liu Y, Yao B (2016) Fasting plasma glucose variability and all-cause mortality among type 2 diabetes patients: a dynamic cohort study in Shanghai. China Sci Rep 6:39633. https:\/\/doi.org\/10.1038\/srep39633","journal-title":"China Sci Rep"},{"issue":"1","key":"2037_CR49","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12933-018-0787-8","volume":"17","author":"M Kosiborod","year":"2018","unstructured":"Kosiborod M, Gomes MB, Nicolucci A et al (2018) Vascular complications in patients with type 2 diabetes: prevalence and associated factors in 38 countries (the DISCOVER study program). Cardiovasc Diabetol 17(1):150. https:\/\/doi.org\/10.1186\/s12933-018-0787-8","journal-title":"Cardiovasc Diabetol"},{"key":"2037_CR50","unstructured":"McGovern AP, Dennis J, Shields B, Pearson E, Hattersley A, Jones A (2018) HbA1c is highly variable in people with type 2 diabetes on stable therapy in both trial and real-world settings: implications for clinical practice. 54th EASD\u2014New clues on metformin, sulfonylureas and insulin, Berlin 2018, ePoster # 710. https:\/\/www.easd.org\/media-centre\/#!resources\/hba1c-is-highly-variable-in-people-with-type-2-diabetes-on-stable-therapy-in-both-trial-and-real-world-settings-implications-for-clinical-practice"},{"issue":"1","key":"2037_CR51","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12916-019-1307-8","volume":"17","author":"AP McGovern","year":"2019","unstructured":"McGovern AP, Dennis JM, Shields BM, Hattersley AT, Pearson ER, Jones AG, MASTERMIND Consortium (2019) What to do with diabetes therapies when HbA1c lowering is inadequate: add, switch, or continue A MASTERMIND study? BMC Med 17(1):79. https:\/\/doi.org\/10.1186\/s12916-019-1307-8","journal-title":"BMC Med"},{"issue":"2","key":"2037_CR52","doi-asserted-by":"publisher","first-page":"e0212574","DOI":"10.1371\/journal.pone.0212574","volume":"14","author":"X Liu","year":"2019","unstructured":"Liu X, Xu Y, An M, Zeng Q (2019) The risk factors for diabetic peripheral neuropathy: a meta-analysis. PLoS ONE 14(2):e0212574. https:\/\/doi.org\/10.1371\/journal.pone.0212574","journal-title":"PLoS ONE"},{"issue":"2","key":"2037_CR53","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/jdi.13652","volume":"13","author":"J Pan","year":"2022","unstructured":"Pan J, Yan X, Li F, Zhang Y, Jiang L, Wang C (2022) Association of glycemic variability assessed by continuous glucose monitoring with subclinical diabetic polyneuropathy in type 2 diabetes patients. J Diabetes Investig 13(2):328\u2013335. https:\/\/doi.org\/10.1111\/jdi.13652","journal-title":"J Diabetes Investig"},{"issue":"7","key":"2037_CR54","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s00592-018-1144-9","volume":"55","author":"R Scicali","year":"2018","unstructured":"Scicali R, Rosenbaum D, Di Pino A et al (2018) An increased waist-to-hip ratio is a key determinant of atherosclerotic burden in overweight subjects. Acta Diabetol 55(7):741\u2013749. https:\/\/doi.org\/10.1007\/s00592-018-1144-9","journal-title":"Acta Diabetol"},{"issue":"9","key":"2037_CR55","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1007\/s00125-012-2620-3","volume":"55","author":"MK Rutter","year":"2012","unstructured":"Rutter MK (2012) Low HbA1c and mortality: causation and confounding. Diabetologia 55(9):2307\u20132311. https:\/\/doi.org\/10.1007\/s00125-012-2620-3","journal-title":"Diabetologia"},{"issue":"6","key":"2037_CR56","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.jdiacomp.2015.05.002","volume":"29","author":"L Monnier","year":"2015","unstructured":"Monnier L, Colette C (2015) Association of HbA1c variability with atherosclerosis in diabetes: Simple marker, risk factor or statistical bias? J Diabetes Complicat 29(6):745\u2013746. https:\/\/doi.org\/10.1016\/j.jdiacomp.2015.05.002","journal-title":"J Diabetes Complicat"},{"key":"2037_CR57","doi-asserted-by":"publisher","first-page":"1302811","DOI":"10.1155\/2021\/1302811","volume":"2021","author":"S Abd ElHafeez","year":"2021","unstructured":"Abd ElHafeez S, D\u2019Arrigo G, Leonardis D, Fusaro M, Tripepi G, Roumeliotis S (2021) Methods to analyze time-to-event data: the Cox Regression analysis. Oxid Med Cell Longev 2021:1302811. https:\/\/doi.org\/10.1155\/2021\/1302811","journal-title":"Oxid Med Cell Longev"},{"issue":"8","key":"2037_CR58","doi-asserted-by":"publisher","first-page":"e10047","DOI":"10.7759\/cureus.10047","volume":"12","author":"A George","year":"2020","unstructured":"George A, Stead TS, Ganti L (2020) What\u2019s the risk: differentiating risk ratios, odds ratios, and hazard ratios? Cureus 12(8):e10047. https:\/\/doi.org\/10.7759\/cureus.10047","journal-title":"Cureus"},{"issue":"3","key":"2037_CR59","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1111\/biom.13197","volume":"76","author":"TJ VanderWeele","year":"2020","unstructured":"VanderWeele TJ (2020) Optimal approximate conversions of odds ratios and hazard ratios to risk ratios. Biometrics 76(3):746\u2013752. https:\/\/doi.org\/10.1111\/biom.13197","journal-title":"Biometrics"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-023-02037-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00592-023-02037-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-023-02037-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T04:03:44Z","timestamp":1682741024000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00592-023-02037-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,30]]},"references-count":59,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["2037"],"URL":"https:\/\/doi.org\/10.1007\/s00592-023-02037-8","relation":{},"ISSN":["1432-5233"],"issn-type":[{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,30]]},"assertion":[{"value":"20 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This meta-analysis does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights disclosure"}},{"value":"No identifying information from individual patients was retrieved or published at any stage by any of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}